Literature DB >> 21796372

Tumor-stromal interactions of the bone microenvironment: in vitro findings and potential in vivo relevance in metastatic lung cancer models.

Diego Luis-Ravelo1, Iker Antón, Silvestre Vicent, Igor Hernández, Karmele Valencia, Carolina Zandueta, Susana Martínez-Canarias, Alfonso Gúrpide, Fernando Lecanda.   

Abstract

Lung cancer comprises a large variety of histological subtypes with a frequent proclivity to form bone metastasis; a condition associated with dismal prognosis. To identify common mechanisms in the development of osteolytic metastasis, we systematically screened a battery of lung cancer cell lines and developed three models of non-small cell lung cancer (NSCLC) with a common proclivity to form osseous lesions, which represented different histological subtypes. Comparative analysis revealed different incidences and latency times. These differences were correlated with cell-type-specific secretion of osteoclastogenic factors, including macrophage inflammatory protein-1α, interleukin-8 and parathyroid hormone-related protein, some of which were exacerbated in conditions that mimicked tumor-stroma interactions. In addition, a distinct signature of matrix metalloproteinase (MMP) activity derived from reciprocal tumor-stroma interactions was detected for each tumor cell line. Thus, these results suggest subtle differences in the mechanisms of bone colonization for each lung cancer subtype, but share, although each to a different degree, dual MMP and osteoclastogenic activities that are differentially enhanced upon tumor-stromal interactions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21796372     DOI: 10.1007/s10585-011-9409-5

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  40 in total

1.  Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival.

Authors:  Xiaolan Zhou; Jin Lin Wang; John Lu; Yanping Song; Keith S Kwak; Qingsheng Jiao; Robert Rosenfeld; Qing Chen; Thomas Boone; W Scott Simonet; David L Lacey; Alfred L Goldberg; H Q Han
Journal:  Cell       Date:  2010-08-20       Impact factor: 41.582

2.  Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-kappaB ligand pathway.

Authors:  Manali S Bendre; Aaron G Margulies; Brandon Walser; Nisreen S Akel; Sudeepa Bhattacharrya; Robert A Skinner; Frances Swain; Vishnu Ramani; Khalid S Mohammad; Lisa L Wessner; Alfredo Martinez; Theresa A Guise; John M Chirgwin; Dana Gaddy; Larry J Suva
Journal:  Cancer Res       Date:  2005-12-01       Impact factor: 12.701

3.  Involvement of parathyroid hormone-related protein in experimental cachexia induced by a human lung cancer-derived cell line established from a bone metastasis specimen.

Authors:  H Iguchi; E Onuma; K Sato; K Sato; E Ogata
Journal:  Int J Cancer       Date:  2001-10-01       Impact factor: 7.396

4.  The cost of treatment of skeletal-related events in patients with bone metastases from lung cancer.

Authors:  Thomas Delea; Corey Langer; James McKiernan; Martin Liss; John Edelsberg; Jane Brandman; Jennifer Sung; Monika Raut; Gerry Oster
Journal:  Oncology       Date:  2004       Impact factor: 2.935

5.  The differential effects of mutant p53 alleles on advanced murine lung cancer.

Authors:  Erica L Jackson; Kenneth P Olive; David A Tuveson; Roderick Bronson; Denise Crowley; Michael Brown; Tyler Jacks
Journal:  Cancer Res       Date:  2005-11-15       Impact factor: 12.701

Review 6.  Mechanisms of cancer metastasis to the bone.

Authors:  Juan Juan Yin; Claire B Pollock; Kathleen Kelly
Journal:  Cell Res       Date:  2005-01       Impact factor: 25.617

7.  An experimental model of bone metastasis by human lung cancer cells: the role of parathyroid hormone-related protein in bone metastasis.

Authors:  H Iguchi; S Tanaka; Y Ozawa; T Kashiwakuma; T Kimura; T Hiraga; H Ozawa; A Kono
Journal:  Cancer Res       Date:  1996-09-01       Impact factor: 12.701

Review 8.  Cancer statistics, 2004.

Authors:  Ahmedin Jemal; Ram C Tiwari; Taylor Murray; Asma Ghafoor; Alicia Samuels; Elizabeth Ward; Eric J Feuer; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2004 Jan-Feb       Impact factor: 508.702

Review 9.  Modeling metastasis in vivo.

Authors:  Chand Khanna; Kent Hunter
Journal:  Carcinogenesis       Date:  2004-09-09       Impact factor: 4.944

Review 10.  Skeletal complications of malignancy.

Authors:  R E Coleman
Journal:  Cancer       Date:  1997-10-15       Impact factor: 6.860

View more
  5 in total

1.  RHOB influences lung adenocarcinoma metastasis and resistance in a host-sensitive manner.

Authors:  Diego Luis-Ravelo; Iker Antón; Carolina Zandueta; Karmele Valencia; María-José Pajares; Jackeline Agorreta; Luis Montuenga; Silvestre Vicent; Ignacio I Wistuba; Javier De Las Rivas; Fernando Lecanda
Journal:  Mol Oncol       Date:  2013-11-12       Impact factor: 6.603

2.  Behaviour of mesenchymal stem cells from bone marrow of untreated advanced breast and lung cancer patients without bone osteolytic metastasis.

Authors:  Valeria B Fernández Vallone; Erica L Hofer; Hosoon Choi; Raúl H Bordenave; Emilio Batagelj; Leonardo Feldman; Vincent La Russa; Daniela Caramutti; Federico Dimase; Vivian Labovsky; Leandro M Martínez; Norma A Chasseing
Journal:  Clin Exp Metastasis       Date:  2012-09-30       Impact factor: 5.150

3.  Receptor of activated protein C promotes metastasis and correlates with clinical outcome in lung adenocarcinoma.

Authors:  Iker Antón; Eva Molina; Diego Luis-Ravelo; Carolina Zandueta; Karmele Valencia; Cristina Ormazabal; Susana Martínez-Canarias; Naiara Perurena; María José Pajares; Jackeline Agorreta; Luis M Montuenga; Victor Segura; Ignacio I Wistuba; Javier De Las Rivas; José Hermida; Fernando Lecanda
Journal:  Am J Respir Crit Care Med       Date:  2012-03-29       Impact factor: 21.405

4.  Colony-stimulating factor 1 potentiates lung cancer bone metastasis.

Authors:  Jaclyn Y Hung; Diane Horn; Kathleen Woodruff; Thomas Prihoda; Claude LeSaux; Jay Peters; Fermin Tio; Sherry L Abboud-Werner
Journal:  Lab Invest       Date:  2014-01-27       Impact factor: 5.662

5.  Characterization of a murine model of metastatic human non-small cell lung cancer and effect of CXCR4 inhibition on the growth of metastases.

Authors:  Arvind K Singla; Charlene M Downey; Gwyn D Bebb; Frank R Jirik
Journal:  Oncoscience       Date:  2015-02-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.